Understanding ZIO-101 (Darinaparsin):IMF
The activity of Darinaparsin against cul- tured myeloma cells and transplanted tumors ... Darinaparsin represents a new class of small. molecule cancer therapy ...Leukemia Journal Publishes Results from Darinaparsin Study | Reuters
Study Suggests Potentially Broader Therapeutic Spectrum for Darinaparsin than Inorganic Arsenic NEW YORK--(Business Wire)-- ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP) ...ZIOPHARM Oncology, Inc. - Leukemia Journal Publishes Results from ...
Darinaparsin than Inorganic Arsenic ... The study showed that darinaparsin is highly active in vitro against certain ... Darinaparsin induces cell cycle arrest ...ZIOPHARM Oncology, Inc. - ZIOPHARM Presents Darinaparsin Molecular ...
In contrast to ATO, darinaparsin is not a substrate for the multi-drug ... In addition, darinaparsin induces cell death despite overexpression of MRP1/ABCC1. ...Leukemia Journal Publishes Results From Darinaparsin Study
ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP) announced the publication of results from a pre-clinical study of darinaparsin (ZIO-101) in the July 17, 2008 on line advance ...News: Leukemia Journal Publishes Results from Darinaparsin Study.
ZIOPHARM Oncology, Inc. (NASDAQ:ZIOP) announced today the publication of results from a pre-clinical study of darinaparsin (ZIO-101) in the July 17, 2008 on line ...